Charles River Labs CEO Executes 10b‑5 Buy‑Sell‑Back Plan, Netting $100/share Gain in One Day
Insight into Charles River Laboratories insider trades: how CEO Parisotto’s buy‑sell strategy signals confidence and risk‑aware growth.
3 minutes to read
CHARLES RIVER LABORATORIES